SCHEMBL10222967

SCHEMBL10222967

CCCCNc1cc(C(=O)O)cc(Nc2ccsc2)c1Oc1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.61
▸ USP2 O75604 1/20 0.61
▸ ALDH1A1 P00352 1/20 0.61
▸ CA2 P00918 1/20 0.61
▸ LMNA P02545 1/20 0.61
▸ HPGD P15428 1/20 0.61
▸ TSHR P16473 1/20 0.61
▸ BLM P54132 1/20 0.61
▸ SLC12A2 P55011 1/20 0.61
▸ HIF1A Q16665 1/20 0.61
▸ NPSR1 Q6W5P4 1/20 0.61
▸ HSD17B10 Q99714 1/20 0.61
▸ AQP1 P29972 1/20 0.48
▸ PTGS2 P35354 14/20 0.47
▸ HDAC3 O15379 1/20 0.40
▸ HCAR3 P49019 1/20 0.39
▸ GAA P10253 1/20 0.36
▸ MAPT P10636 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2741864 0.88 ALDH1A1 (0.69) KDM4EUSP2ALDH1A1CA2LMNA
SCHEMBL18993639 0.87 KDM4E (0.60) KDM4EUSP2ALDH1A1CA2LMNA
SCHEMBL2741867 0.84 KDM4E (0.72) KDM4EUSP2ALDH1A1CA2LMNA
SCHEMBL10222972 0.83 LMNA (0.44) KDM4EUSP2ALDH1A1CA2LMNA
SCHEMBL2741865 0.82 KDM4E (0.71) KDM4EUSP2ALDH1A1CA2LMNA
SCHEMBL13283807 0.82 ALDH1A1 (0.61) KDM4EUSP2ALDH1A1CA2LMNA
SCHEMBL2875002 0.82 KDM4E (0.69) KDM4EUSP2ALDH1A1CA2LMNA
SCHEMBL2741873 0.81 CA2 (0.68) KDM4EUSP2ALDH1A1CA2LMNA
SCHEMBL18993714 0.80 KDM4E (0.71) KDM4EUSP2ALDH1A1CA2LMNA
SCHEMBL15495571 0.80 KDM4E (0.67) KDM4EUSP2ALDH1A1CA2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012018635-A2 ARYLSULFONAMIDE DERIVATIVES, COMPOSITIONS, AND METHODS OF USE NEUROTHERAPEUTICS PHARMA, INC. (US) 2012-02-09 — — WO disclosed
WO-2010085352-A2 BUMETANIDE, FUROSEMIDE, PIRETANIDE, AZOSEMIDE, AND TORSEMIDE ANALOGS, COMPOSITIONS AND METHODS OF USE NEUROTHERAPEUTICS PHARMA, INC. (US) 2010-07-29 — — WO disclosed
Send feedback